Drinking a milkshake-style medicine at breakfast seems to feed brain cells starved from Alzheimer's damage, researchers reported Monday. It's one of four promising experimental drugs poised for large-scale testing against the brain-destroying disease.
The milkshake drug, called Ketasyn, is a dramatically different way to approach dementia. It hinges on recent research suggesting diabetic-like changes in brain cells' ability to use sugar for energy play a role in at least some forms of Alzheimer's.
Special fatty acids in Ketasyn offer an alternate food source to rev up those hungry neurons, say researchers.